Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorFernández-Rozadilla, Ceres
dc.contributor.authorSimões, Ana Rita
dc.contributor.authorCarnero, Amancio
dc.contributor.authorCarracedo, Ángel
dc.contributor.authorLleonart Pajarin, Matilde
dc.date.accessioned2022-06-08T09:45:36Z
dc.date.available2022-06-08T09:45:36Z
dc.date.issued2021-01
dc.identifier.citationFernandez-Rozadilla C, Simões AR, Lleonart ME, Carnero A, Carracedo Á. Tumor Profiling at the Service of Cancer Therapy. Front Oncol. 2021 Jan;10:3038.
dc.identifier.issn2234-943X
dc.identifier.urihttps://hdl.handle.net/11351/7641
dc.descriptionCancer treatment; Personalized medicine; Precision oncology
dc.description.abstractCancer treatment options have evolved significantly in the past few years. From the initial surgical procedures, to the latest next-generation technologies, we are now in the position to analyze and understand tumors in a one-by-one basis and use that to our advantage to provide with individualized treatment options that may increase patient survival. In this review, we will focus on how tumor profiling has evolved over the past decades to deliver more efficient and personalized treatment options, and how novel technologies can help us envisage the future of precision oncology toward a better management and, ultimately, increased survival.
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Oncology;10
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCàncer - Tractament
dc.subjectMedicina personalitzada
dc.subject.meshNeoplasms
dc.subject.mesh/therapy
dc.subject.meshPrecision Medicine
dc.titleTumor Profiling at the Service of Cancer Therapy
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fonc.2020.595613
dc.subject.decsneoplasias
dc.subject.decs/terapia
dc.subject.decsmedicina de precisión
dc.relation.publishversionhttps://doi.org/10.3389/fonc.2020.595613
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Fernandez-Rozadilla C, Simões AR] Grupo de Medicina Xenómica (USC), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. [Lleonart ME] Grup de Recerca Biomèdica en Cèl•lules Mare del Càncer, Vall d´Hebron Institut de Recerca (VHIR), Barcelona, Spain. Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Madrid, Spain. [Carnero A] Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Madrid, Spain. Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Seville, Spain. [Carracedo Á] Grupo de Medicina Xenómica (USC), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. Grupo de Medicina Xenómica (USC), Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain
dc.identifier.pmid33505911
dc.identifier.wos000611285600001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record